SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA


KARABULUT M. , Afsar C. U. , KARABULUT S., PEKER K. D. , GEMICI E., Dagoglu N., ...More

ACTA MEDICA MEDITERRANEA, vol.33, no.4, pp.613-619, 2017 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.19193/0393-6384_2017_4_091
  • Title of Journal : ACTA MEDICA MEDITERRANEA
  • Page Numbers: pp.613-619

Abstract

Background: Pancreatic adenocarcinoma (PA) is a very lethal malignancy. Different parameters have been found to be predictive and prognostic. This study was conducted to investigate the serum levels of interleukin-32 (IL-32) in patients with PA and the relationship with tumor progression and known prognostic parameters.